Hospital-Acquired Infections Create Market For Novel Tests And Interventions
This article was originally published in The Gray Sheet
Executive Summary
A stream of new products designed to prevent hospital-acquired infections are hitting the market as state and federal legislators and the public are pressuring hospitals and industry to reduce infection risks
You may also be interested in...
CareFusion Will Expand IV Infusion Portfolio With $225 Mil. Medegen Buy
CareFusion says its planned $225 million acquisition of needleless intravenous infusion device maker Medegen will improve its ability to compete on claims of reducing hospital-acquired infections
CareFusion Will Expand IV Infusion Portfolio With $225 Mil. Medegen Buy
CareFusion says its planned $225 million acquisition of needleless intravenous infusion device maker Medegen will improve its ability to compete on claims of reducing hospital-acquired infections
HHS Wants Draft Hospital-Acquired Infection Plan By Jan. 20
The Department of Health and Human Services intends to produce a new draft action plan for attacking hospital-acquired infections before the next U.S. president takes office in January, a department official said Sept. 23